Company Announcements

Environnement SA acquired Iséo, an environmental information systems company, in 2007, for €1 million ($1.4 million). Iséo had sales of €2.2 million ($2.8 million) in 2006.

Ocimum Biosolutions raised $17 million from the Kubera Cross Border Fund in a Series B round of financing.

Clemex Technologies announced in January that it is reviewing strategic options for the company, including the sale of the company.

UK lab supplier Kinesis acquired Abimed Analysen Technik GmbH, which distributes liquid handling and chromatography products, in January.

The Orange County Business Journal reported in February that Beckman Coulter will move its operations from Fullerton, California, to its existing facility in Brea, California, by the end of 2009. The Fullerton location, which has over 900 employees, houses the corporate offices and life sciences business.

Predictive Biosciences appointed Dr. Martin Madaus, president, CEO and chairman of Millipore, to its Board in January.

Siemens Water Technologies promoted Chuck Gordon, executive vice president of the Systems business, to president and CEO in February.

Revenues for Roche’s Applied Science rose 11% to CHF 692 million ($576.7 million) in 2007, driven by sales of the LightCycler 480, DNA sequencers and research reagents. Nimblegen and 454 Life Sciences contributed revenues of CHF 9 million ($7.5 million) and CHF 6 million ($5 million) and posted operating losses of CHF 18 million ($15 million) and CHF 11 million ($9.2 million), respectively.

Symyx Technologies’ 2007 revenues were flat at $125.1 million (see page 12). Software, Tools, and Materials and IP Licensing sales increased 24.9%, 4.4% and 3.3% to 25%, 32% and 5% of sales, respectively. Research sales declined 8.3% to 38% of company sales.

OI reduced the size of its Board from seven to five directors.

Strategic Diagnostics named Francis M. DiNuzzo, formerly vice president and general manager of Agilent’s Integrated Biology Solutions Business, chief commercial officer effective February 25.

PerkinElmer elected Patrick J. Sullivan, executive chairman of Hologic, to its Board in February.

Harvard Bioscience’s 2007 revenues increased 9.5% to $83.4 million (see IBO 3/15/08), but were flat on an organic basis. Self-manufactured products represented 87% of revenues, and sales from nonUS operations represented 58% of revenues. The company forecasts 2008 revenues of $94.0–$96.0 million.

Product Introductions

Intertek launched a Laboratory Management Services division in North Eastern China in late 2007.